Back
Sarepta Therapeutics Vs. RH Industry Stock Comparison
Sell
43
SRPT
Sarepta Therapeutics
Last Price:
160.73
Seasonality Move:
13.83%
Sell
24
RH
RH
Last Price:
215.93
Seasonality Move:
15.66%
Sell
43
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $123.56. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
RH (RH)
is a Sell
Is RH a Buy, Sell or Hold?
- The current RH [RH] share price is $217.83. The Score for RH is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- RH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $123.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RH Stock Price Chart
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.66 | Sell |
| Relative Strength Index (14 RSI): | 50.38 | Buy |
| Chaikin Money Flow: | 1128064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.42 - 129.08) | Sell |
| Bollinger Bands (100): | (120.21 - 131.53) | Sell |
RH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.83 | Sell |
| Relative Strength Index (14 RSI): | 31.81 | Sell |
| Chaikin Money Flow: | 206377 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (243.19 - 284.93) | Sell |
| Bollinger Bands (100): | (249.06 - 291.24) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.23 | Buy |
| 20-day SMA: | 121.86 | Buy |
| 50-day SMA: | 125 | Sell |
| 200-day SMA: | 114.69 | Buy |
| 8-day EMA: | 121.07 | Buy |
| 20-day EMA: | 122.55 | Buy |
| 50-day EMA: | 124.12 | Sell |
| 200-day EMA: | 119.07 | Buy |
RH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 251.83 | Sell |
| 20-day SMA: | 259.29 | Sell |
| 50-day SMA: | 262.75 | Sell |
| 200-day SMA: | 268.95 | Sell |
| 8-day EMA: | 242.79 | Sell |
| 20-day EMA: | 257.04 | Sell |
| 50-day EMA: | 265.03 | Sell |
| 200-day EMA: | 274.77 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.04 per share, an increase next quarter of $1.33 per share, an increase this year of $5.96 per share, and an increase next year of $5.92 per share.
RH Earnings Growth & RH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.24 per share, an increase next quarter of $0.43 per share, a decrease this year of $16.71 per share, and a decrease next year of $0.16 per share.
Sarepta Therapeutics Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RH Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||